U.S. pharmaceutical companies – The Milli Chronicle

Friday, October 17, 2025

Latest:

U.S. Expands Counter-Narcotics Operations in the Caribbean with Renewed Focus on Regional Security and Cooperation
Pharma Giants Lead the Way in Affordable, Direct-to-Consumer Healthcare Transformation
G20 Strengthens Commitment to Debt Sustainability, Boosts Support for Developing Countries
Indian Refiners Make Strategic Move with Rare Purchases of Guyanese Crude, Strengthening Energy Ties and Diversifying Supplies
RBI Reaffirms Commitment to Rupee Stability with Pre-Market Dollar Sales

Factual Version of a Story

Latest News World

NewsDesk Milli Chronicle October 17, 2025October 17, 2025 affordable medicines, American drug cost reduction, AstraZeneca discounts, Bristol-Myers Squibb price cuts, direct-to-consumer drug sales, drug price reform, Eli Lilly Zepbound online sales, Merck fertility treatment discounts, Novo Nordisk Ozempic Wegovy offers, patient-first healthcare model, Pfizer Medicaid drug pricing deal, pharma industry transformation, pharmaceutical innovation, reduced prescription drug prices, Sanofi insulin price cap, telehealth partnerships, Trump administration healthcare initiatives, TrumpRx.gov launch, U.S. healthcare affordability, U.S. pharmaceutical companies, Washington healthcare news, women’s telehealth provider Wisp, Zealand Pharma direct-to-patient model

Pharma Giants Lead the Way in Affordable, Direct-to-Consumer Healthcare Transformation

Washington – In a major move set to reshape the U.S. healthcare industry, several global pharmaceutical companies have announced direct-to-consumer